Recent Headlines
National Brain Tumor Society Statement on Harold Varmus, MD, Director of the National Cancer Institute and Nobel Laureate
Largest brain tumor nonprofit in the U.S. thanks Harold Varmus for his service and leadership. - March 14, 2015 - National Brain Tumor Society
China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech
China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC
Clinical Study Published in Neurology Finds That Electrocore’s Non-Invasive Vagus Nerve Stimulation is Effective in Treating Cluster Headaches
An open-label study published in the journal Neurology, reports that electroCore’s non-invasive Vagus Nerve stimulation (nVNS) device, gammaCore, is practical and effective as an acute and preventative treatment in cluster headache. - March 05, 2015 - electroCore
PBTF Names Early Career Development Grant Awardees
The Pediatric Brain Tumor Foundation has awarded its first Early Career Development grants to three up-and-coming pediatric brain tumor researchers studying medulloblastoma and ependymoma. These awards support talented pediatric brain tumor researchers who are early in their career. The recipients... - March 05, 2015 - Pediatric Brain Tumor Foundation
Leader in Cryostorage Announces Partnership with Fertility Within Reach to Offer Financial Assistance
Program extends access to Fertility Preservation services by offering financial assistance. - March 04, 2015 - ReproTech, LLC
Pipette.com Announces Limited Time Offer on the Vortex-Genie 2
Pipette.com announced special pricing on Vortex Genie® 2. Lab technicians looking for a high quality and reliable vortex mixer will benefit from this offer. - March 02, 2015 - Pipette.com
Surgical Science Wins ACG Minnesota BOLD Award
Surgical Science, leading developer of virtual reality surgical simulation training systems, was the recipient of the 2015 Small Corporate BOLD Award from the Association for Corporate Growth (ACG) Minnesota. Now in their third year, the awards were created by ACG to recognize exceptionally... - February 28, 2015 - Surgical Science Inc
AveXis Announces the Formation of Its European Subsidiary, AveXis EU, Ltd.
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced the formation of its EU-based wholly-owned subsidiary, AveXis EU, Ltd. The subsidiary will allow AveXis... - February 27, 2015 - AveXis Inc.
MLS® Laser Therapy by ASAlaser: Effective Response to the Treatment of Pathologies of Companion Animals
As an innovative therapy, MLS® and its devices (Mphi Vet and Mphi Vet Orange) is among the therapeutic solutions adopted with increasing frequency by Veterinary professionals. In Italy as in the World. What’s the goal? To ensure our 4-legged friends a "tailored" cure to go back to feeling good. - February 19, 2015 - ASA srl
Affinity Biologicals Inc. Releases New Feature with Polyclonal Coagulation Antibodies Over Monoclonal Coagulation Antibodies for Quantitative Research
For over 28 years, Affinity Biologicals Inc. has been producing a diverse number of products for research and diagnostic purposes. - February 17, 2015 - Affinity Biologicals
Scientists Change the World - Now They Can Get Published and Rewarded at the Same Time
The “My Science Matters” initiative at Pipette.com will tell the stories of scientists and how their research helps others. Researchers and organizations can easily submit an overview of their work for publication and as an incentive February submission receive shopping credit towards any purchase at Pipette.com. - February 15, 2015 - Pipette.com
Europital Participates at the Next Clinical Trials Innovation Programme 2015
Europital will attend the upcoming Clinical Trials Innovation Programme (CTIP) 2015 that takes place next 3rd and 4th of March in the cosmopolitan city of Munich. - February 14, 2015 - Europital BVBA
Fertility Preservation Network Welcomes Seattle, Washington Area Facility
Program greatly extends access to Fertility Preservation services. - February 12, 2015 - ReproTech, LLC
New Ultra Compact, Negative-Stiffness Vibration Isolator from Minus K Technology Reduces Low-Frequency Vibrations with Less Space Required
New LC-4 isolator can be combined into multi-isolator systems to support heavier payloads while taking up very little room, and using no air or electricity. - February 08, 2015 - Minus K Technology Inc.
Hussian School of Art Opens Relativity School Campus in Los Angeles, CA
Hussian School of Art® has expanded to Los Angeles, California. - February 04, 2015 - Clinical Financial Services
Pipette.com Launches Eppendorf 6-Pack Pipette Bundle
Customized bundle makes it easy for lab technicians to get up and running. The bundle includes 6 Eppendorf Research plus pipettes, 7 packs of pipette tips, and a carousel stand. - February 04, 2015 - Pipette.com
A Review in the European Journal of Neurology Confirms That electroCore’s nVNS is Not Only Safe But Could be Effective Across a Wide Range of Conditions
According to a review in the European Journal of Neurology electroCore's non-invasive vagus nerve stimulation therapy is not only safe but could be effective for a wide range of conditions. - January 30, 2015 - electroCore
Implantable Artificial Kidney Corporation Seals Deal for 500K Funding
Funding will be used for further research and development of their IAK-1 artificial kidney prototype. - January 28, 2015 - Implantable Artificial Kidney Corporation
ASAlaser: New Challenges for 2015
For the new year, the company aims at strengthening the worldwide diffusion of MLS® Laser Therapy for the treatment of temporo-mandibular disorders and craniofacial pain, at introducing Hilterapia® in the U.S. and at consolidating the presence of the Veterinary line in the European and international markets. Among the other tools for its internationalization strategy, training will have a leading role. - January 27, 2015 - ASA srl
Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com
Pipette.com is now offering a limited-time promotional offer on the Eppendorf Centrifuge 5424/5424 R which includes free pipettes. Pipette.com leads the charge by making this exclusive Eppendorf promotion available immediately. - January 24, 2015 - Pipette.com
Applied Spectral Imaging Receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67 - January 24, 2015 - Applied Spectral Imaging
Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare
Publication of "The Notebooks of a Successful Psychopath” of Dr. Willem Martens
“The Notebooks of a Successful Psychopath” is a unique publication. There is only one autobiographical book of psychopaths published before, and this new one is written by a forensic psychiatrist/psychoanalyst. This publication of his Notebooks is a valuable addition to the existing literature. His very honest revelations give us a new perspective on the internal world of the psychopath. - January 17, 2015 - W. Kahn Institute of Theoretical Psychiatry and Neuroscience
Affinity Life Sciences to Produce Lyophilized Chem-Bio Assays for SRC Acumen
SRC Acumen announced the continued and exclusive production of lyophilized qPCR and toxin assays by Affinity Life Sciences. - January 16, 2015 - Affinity Life Sciences
CHI Scientific Releases PrimaCell™ Protocols for Culturing More Than 300 Types of Primary Cells to Speed Biological Discoveries
Brings Standardized Methods to the Research Scientist, Greatly Reducing the Time Needed to Prepare and Culture Critical Tissue and Organ Cells. - January 16, 2015 - CHI Scientific Inc
PenThu® Officially Registered and Available in the Market
Europital announces the official launching and certification attainment of its latest product. From January 2015 “Penthu®: The Future of Medical Management in Clinical Trials” will be available in the market. Penthu® is an innovative and intuitive platform that drives... - January 16, 2015 - Europital BVBA
Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines
Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC
Zenascope® Determines Presence or Lack of Bloodflow During Kidney Surgery, Ensures Selective Ischemia
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, reports that the Zenascope® was deployed in a recent study by investigators at Tulane University that looked at the feasibility of quantitative diffuse reflectance spectroscopy for targeted measurement of renal ischemia during... - January 13, 2015 - Zenalux Biomedical, Inc.
New Book by William Martens "The Firebirds Among the Psychopaths – Development and Remission in Psychopathy"
This book is an attempt to describe and make understandable this rare phenomenon of complete remission in psychopathy and the developmental embedding of it. In this book the history of the concept of psychopathy; the psychosocial, psychodynamic, genetic and neurobiological aspects, the diagnostic... - January 12, 2015 - W. Kahn Institute of Theoretical Psychiatry and Neuroscience
AveXis Closes Its Series C Financing Round with Deerfield Management and Roche Venture Fund
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced it has completed a $10 million financing round led by Deerfield Management and Roche Venture Fund. In... - January 08, 2015 - AveXis Inc.
Major Pipette Distributor Pipette.com Announces Their Holiday in the Lab Contest
Pipette.com is giving their Twitter followers a chance to win free holiday gifts in their Holiday in the Lab Contest. Prizes include pipette-themed shirts, backpacks, and more. - January 01, 2015 - Pipette.com
Colorado BioScience Association Names Primavera Group to Succeed Absolutely PR as Media Relations & Strategic Public Relations Consulting Firm
Colorado BioScience Association (CBSA) has selected the Primavera Group, led by Owner/Principal Sarah Eder, for media relations and strategic PR consulting beginning January 5, 2015. - December 29, 2014 - Colorado BioScience Association
2014 Proves a Successful Year for Major Bioscience Fundings, Including Key Merger and Acquisition Activity in Colorado
Colorado BioScience Association (CBSA) highlights Colorado’s key financings, acquisitions and expansions in the industry during 2014. CBSA plays a key role in promoting Colorado as a dynamic region for bioscience innovation and investment. - December 22, 2014 - Colorado BioScience Association
Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials
Pipette.com announces 3 Sartorius Biohit promotions for labs seeking to maximize purchasing capacity with 2 weeks left out of the year. - December 21, 2014 - Pipette.com
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
ASAlaser 2014: Between Positive Budget and New Projects
Sales growth, encouraging percentages for the installation of their devices, opening new markets for Human and Vet sector: the year that is closing is a solid springboard to dive into a 2015 full of goals to reach. - December 20, 2014 - ASA srl
Ethan Jostad Foundation Gives Gift of Childhood Cancer Research
Non-Profit charity donates to pediatric cancer research for most difficult to treat childhood cancers. - December 20, 2014 - Ethan Jostad Foundation for Childhood Cancer
Theravectys Launches Its New Website & Wins Deloitte’s Technology Fast50 "2014 Biotech d’Avenir" Award
A rewarding November for the promising French biotech: a prestigious prize & an impactful communication tool! Theravectys wins Deloitte Technology Fast 50 “2014 Biotech d’Avenir,” a prize awarded to one of the fastest-growing, most innovative & dynamic biotech company of the year. In addition, Theravectys is proud to announce the launch of its responsive and easy-to-navigate website www.theravectys.com featuring new sections & content. - December 18, 2014 - Theravectys
Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine; Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been featured in the December 15, 2014 issue of CEO/CFO Magazine in which ACT President and CEO Randall B. Riggs discusses PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. - December 17, 2014 - Advanced Cancer Therapeutics
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
ALPCO Releases New Chemiluminescent Human C-peptide ELISA
ALPCO adds to their STELLUX® Chemiluminescent line of assays with the launch of the new Human C-peptide ELISA. - December 10, 2014 - ALPCO
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
Fertility Preservation Network Sponsors 2014 Cancer Fundraiser Event Teams
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in multiple 2014 cancer research fundraisers. ReproTech, Ltd. sponsored its Reno, NV staff and team to participate in... - December 03, 2014 - ReproTech, LLC
MR Solutions Announces the First Installations of Its Second Generation Cryogen Free Magnet Technology for Increased Scientific Capabilities in Preclinical MRI
MR Solutions has introduced its second generation MRI magnet technology to its range of ground breaking 3T and 7T, cryogen free, preclinical scanners. Features of this new technology include variable field operation, higher intrinsic magnetic field homogeneity, larger fields of view (FOV)... - December 03, 2014 - MR Solutions
electroCore CEO, JP Errico, Emphasizes the Importance of Early Collaboration with Patients Group, Providers, and Payors When Introducing Innovative Technologies
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers... - November 28, 2014 - electroCore
8.5K in Los Angeles Raises $33,000 for PBTF
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised $33,000 in Los Angeles on Nov. 22. The 8.5K event at Griffith Park honored local children with brain tumors. These Stars were Adam, Bella, Brittney, Caitlyn, Cassie,... - November 27, 2014 - Pediatric Brain Tumor Foundation
Penthu Will be Officially Presented on 3rd of December 2014 in Basel
Europital has established a date for presenting its latest project: PenThu, a global platform developed by clinical research professionals for clinical research professionals. The event will take place next 3rd of December in Basel, concretely at the Radisson Blu Hotel, situated in the heart of... - November 27, 2014 - Europital BVBA
Advanced Cancer Therapeutics’ PFK-158 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been chosen by Informa and Kantar Health as one of the “2014 Top 10 Most Interesting Oncology Projects to Watch” for its compound, PFK-158. PFK-158 is a small... - November 27, 2014 - Advanced Cancer Therapeutics